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Abstract
Particularly interesting new cysteine–histidine–rich
protein (PINCH), a LIM domain adapter protein that
functions in the integrin and growth factor signal
transduction pathway, is upregulated in stroma asso-
ciated with many common cancers. The finding
suggested that PINCH may be involved in promoting
tumor–stromal interactions that support tumor prog-
ression, and, if so, tumors with abundant PINCH
stromal staining may have a worse prognosis. To test
this hypothesis, 174 primary colorectal adenocarci-
nomas with 39 distant normal mucosa samples and
26 metastases in the lymph nodes were studied by
immunohistochemistry, and 7 additional colon tumors
were studied by Western blot analysis and immuno-
fluorescence. The abundance of PINCH protein in
stroma increased from normal mucosa to primary
tumor to metastasis (P < .05), and was more intense at
the invasive margin than it was in the intratumoral
stroma. Strong stromal immunostaining for PINCH
was shown to predict a worse outcome (rate ratio 2.1,
95% CI 1.16–3.37, P = .01), independent of Dukes
stage, growth pattern, and tumor differentiation.
PINCH was detected in fibroblasts, myofibroblasts,
and a proportion of endothelial cells of the tumor
vasculature, supporting the involvement of PINCH in
promoting tumor–stromal interactions that support
tumor progression. Interestingly, stromal staining for
PINCH was an independent prognostic indicator in
colorectal cancer.
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Introduction
Particularly interesting new cysteine–histidine–rich protein
(PINCH) was originally identified by Rearden [1] as a widely
expressed, evolutionarily conserved protein that consists
primarily of five LIM (double zinc finger) domains and
contains an autoepitope homologous to ‘‘senescent cell
antigen.’’ The PINCH gene is located on chromosome
2q12.2, and the protein functions as an adapter protein for
signal transduction in the integrin and growth factor pathways
[2–4]. Recently, PINCH protein was shown to be markedly
upregulated in the tumor-associated stroma of many common
cancers, including breast, prostate, lung, skin, and colon
cancers [5]. In that study, PINCH was noted to be especially
abundant in stromal cells at the invasive margin in these
tumors, a region where signaling in the integrin and growth
factor pathways is known to occur. The phenomenon of the
‘‘intense at invasive edges’’ was particularly observed in breast
cancers (n = 33) and was not potentially described in colon
cancers because only five cases were included.
Adapter proteins such as PINCH play important roles in the
formation, compartmentalization, and stabilization of signaling
complexes, and therefore increased PINCH abundance may
augment signal transduction in stromal cells at the tumor edge,
leading to downstream activation of pathways important in
paracrine interactionswith tumor cells. Because tumor–stromal
interactions are important for cancer progression, it is possible
that increased PINCH in stromal cells may have a role in
promoting tumor progression, and, if so, tumors with abundant
stromal staining for PINCH may be expected to have a worse
prognosis. The aim of this study was to test this hypothesis by
determining whether immunostaining of the tumor stroma for
PINCH can predict outcome in colorectal cancer.
Materials and Methods
Patients
For immunohistochemistry, formalin-fixed paraffin-embedded
tissue blocks were obtained from 174 randomly selected pa-
tients with primary colorectal adenocarcinoma who underwent
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surgical resection at Linko¨ping Hospital (Linko¨ping, Swe-
den) and Vrinnevi Hospital (Norko¨ping, Sweden). The study
also included 39 normal mucosa specimens (29 of them
were matched with primary tumors) taken from the margin
of distant resection (distant normal mucosa) and 26 metas-
tases (25 of them were matched with primary tumors) from
the regional lymph nodes. Among the primary tumors,
96 cases had adjacent normal mucosa including dysplastic
lesions. The patients’ sex, age, tumor location, and Dukes
stage were obtained from surgical and/or pathologic records
at Linko¨ping and Vrinnevi Hospitals. The mean age was
71 years (range from 34 to 94 years). The growth pattern
was based on the patterns of growth and invasiveness.
Differentiation was graded as better (good + moderate) and
worse differentiation. Inflammatory infiltration was graded
as weak and strong infiltration.
For Western blot analysis and immunofluorescence, sev-
en additional colon cancer specimens were obtained freshly
at the University of California, San Diego Medical Center,
frozen immediately, and stored at 80jC until use.
Immunohistochemistry
The preparation, specificity, and reliability of the rabbit
polyclonal PINCH antibody used in the study were as de-
scribed previously [5,6]. Five-micrometer sections were
deparaffinized and rehydrated, and then were treated by
high-pressure cooking with 0.01 M Tris–EDTA buffer (pH
9.0) for 10 minutes and kept at room temperature (RT) for
30 minutes. The sections were incubated with 3% H2O2–
methanol for 20 minutes and washed with phosphate-buff-
ered saline (PBS; pH 7.4). The sections were further treated
with protein block solution (Dako, Carpinteria, CA) for
10 minutes. After removing the solution, the sections were
incubated with rabbit anti-PINCH at 2 mg/ml in antibody
diluent (Dako) for 1 hour, followed by rinsing with PBS.
Subsequently, the sections were incubated with a goat
anti– rabbit/mouse, coupled with peroxidase provided by
the Dako ChemMate EnVision Detection Kit (Dako) for
25 minutes, and washed with PBS. The peroxidase reaction,
using 3,3V-diaminobenzidine tetrahydrochloride, was per-
formed (Dako A/S, Glostrup, Denmark) for 8 minutes. Sec-
tions known to stain positively were included as positive
controls. The negative control used PBS instead of the
primary antibody. In all staining procedures, the positive
controls showed clear staining, and there was no staining
in the negative controls.
The sections were microscopically examined and scored
independently by two of the authors without any information
on the clinicopathologic data. PINCH staining was observed
in the cytoplasm of fibroblasts in stroma. The staining
intensity was scored as negative, weak, moderate, or strong,
respectively, in 1) the entire tumor area, 2) tumor invasive
margin, and 3) inner tumor area, irrespective of the percent-
age of positive cells. The percentage of stained cells was
classified as < 25% staining, 25% to 49%, 50% to 75%, or
> 75%, irrespective of the staining intensity. In the seven
cases with discrepant scoring, a consensus score was
reached by using a dual-headed microscope after reexami-
nation and discussion. To avoid artificial effects, cells in
areas with necrosis, with poor morphology, or in the margins
of sections were not counted.
Western Blot Analysis
Frozen colon cancer tissue was thawed and mechani-
cally dissociated using 1/4-in. stainless steel beads and a
Mini-Beadbeater (Biospec Products, Bartlesville, OK) into
the lysis buffer, 1% sodium dodecyl sulphate (SDS)/PBS
containing a protease inhibitor cocktail (Complete; Roche,
Indianapolis, IN). Protein concentrations of the lysates were
determined by the DC protein assay (BioRad, Hercules, CA).
Samples in loading buffer were boiled for 5 minutes in the
presence of 2-mercaptoethanol and dithiothreitol. Solubilized
proteins were separated by electrophoresis in 10% SDS
polyacrylamide gels and transferred to nitrocellulose
(Hybond-ECL; Amersham, Piscataway, NJ) by electroblot-
ting in 25 mM Tris, 192 mM glycine, 20% methanol, pH 8.3.
Equivalency of protein transfer was confirmed by staining the
nitrocellulose membrane with Ponceau S. Nitrocellulose
membranes were blocked for 30 minutes with 5% nonfat
dried milk in Tris-buffered saline containing 0.1% Tween-20
(TBS-T), pH 7.5, and then reacted overnight at 4jC with
rabbit anti-PINCH at 1 mg/ml in 5% nonfat milk/TBS-T.
Reactions were detected using horseradish peroxidase–
conjugated anti–rabbit Ig (Amersham) at 1:5000 for 1 hour
at RT followed by enhanced chemiluminescence (ECL;
Amersham).
Immunofluorescence
Colon cancer frozen sections were air-dried overnight,
fixed in cold acetone for 10 minutes, and blocked with 1%
bovine serum albumin (BSA; Vector, Burlingame, CA) for
30 minutes. Sections were reacted with rabbit anti-PINCH
at 10 mg/ml for 1 hour at RT, washed in TBS, and then
reacted with Alexa-Fluor 488 goat anti– rabbit Ig (1:250;
Molecular Probes, Eugene, OR) for 1 hour. Subsequently,
sections were reacted with either mouse anti –human
smooth muscle actin (SMA) (1:50; Dako) or with mouse
anti–human CD31 (1:20; Dako) for 1 hour at RT, washed,
and then reacted with Alexa-Fluor 546 goat anti–mouse Ig
(1:250) for 1 hour. After washing, sections were mounted
with Slow-Fade (Molecular Probes) and examined by fluo-
rescence microscopy.
Statistical Analysis
The significance of the difference in intensity of PINCH
expression between normal mucosa samples and primary
tumors and metastases was tested by chi square analysis or
McNemar’s method. The relationships between PINCH ex-
pression and other factors were examined by chi square
analysis. The relationship between PINCH expression and
survival was tested using Cox’s proportional hazard model.
Survival curves were calculated using the Kaplan-Meier
method. Two-sided P values of < 5% were considered as
statistically significant.
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Results
PINCH Expression in Normal Mucosa, Primary Tumor, and
Metastasis
PINCH staining was present in the cytoplasm of fibro-
blasts in the stroma, whereas normal epithelial and tumor
cells did not show any staining (Figure 1).
Table 1 presents staining intensity for PINCH in the
distant normal mucosa, adjacent normal mucosa, entire
tumor of primary tumors, invasive margin of primary tumors
(excluding nine cases that did not have visible invasive
margin), and metastases in the lymph nodes.
The intensity of PINCH expression was increased from
distant or adjacent normal mucosa (no significant difference
in the staining between distant and adjacent normal mucosa,
P = .74) to primary tumor (P = .0004, P < .0001) to metastasis
(P = .003) either in the unmatched or matched cases
(matched distant or adjacent normal mucosa versus primary
tumor, P = .01, P < .0001, and primary tumor versus
metastasis, P = .02). Figure 2 presents the seven groups
of PINCH staining patterns in 14 cases that had a complete
data set including distant and adjacent normal mucosa,
primary tumor, and metastasis. The staining intensity tended
to be increased from distant to adjacent normal mucosa to
primary tumor to metastasis (Figure 1, A–C). Six cases
(groups 1, 3, and 7) showed increased staining from the
distant normal mucosa to the primary tumor to metastasis;
four cases (groups 2 and 5) showed increased staining from
the distant normal mucosa to primary tumor, but were equal
in primary tumor and metastasis. The remaining four cases
(groups 4 and 6) showed the same staining in the distant
normal mucosa and primary tumor but increased in metas-
tasis. Regarding adjacent normal mucosa including dysplas-
tic lesion, comparing with distant normal mucosa, 9 of 14
(groups 1, 2, 3, and 5) showed increased staining, two
(group 4) showed the same, and three (groups 6 and 7)
presented weaker staining. Comparing with primary tumor,
8 of 14 adjacent mucosa cases (groups 1, 2, 6, and 7)
showed decreased staining and the remaining six (groups
3, 4, and 5) showed equal staining.
Comparing the PINCH intensity at the invasive margin
with that in the inner tumor area, 112 (68%) had stronger
staining at the invasive margin (Figure 3), 41 (25%) showed
the same staining, and only 12 (7%) had weaker staining.
Considering staining percentage in 172 primary tumors
(excluding two cases that had small stained areas), 23%
showed < 25%, 23% showed 25% to 49%, 32% showed
50% to 75%, and 22% showed > 75% staining. We did not
evaluate the staining percentage at tumor invasive margin,
in normal mucosa, and in metastasis due to the small
stained areas.
PINCH Expression in Primary Tumors in Relation to
Clinicopathologic Variables
According to the similarities of the clinicopathologic fea-
tures, the cases with negative, weak, andmoderate stainings
were grouped as a weakly staining group, and the cases with
strong staining were grouped as a strongly staining group.
Similarly, the staining percentage was classified as low
expression and high expression using 50% as a cutoff
point, regardless of the staining intensity.
As shown in Table 2, the frequency of strong PINCH
expression was higher in tumors with better differentiation
(P = .02) and weaker inflammatory infiltration (P = .04).
Besides, we did not find associations of PINCH expression
with other factors (P > .05).
Furthermore, patients with strong PINCH-stained tumors
at the invasive margins had a poorer prognosis than those
with weak staining (P = .049; Figure 4). Even in multivariate
analysis, the expression was still related to survival, inde-
pendent of sex, age, tumor location, Dukes stage, growth
pattern, differentiation, and inflammatory infiltration (P = .01;
Table 3).
Neither the intensity nor the percentage of PINCH ex-
pression in the entire primary tumor was significantly related
to the clinicopathologic factors studied above (P > .05, data
not shown).
Figure 1. A case presented PINCH immunohistochemical staining in the
cytoplasm of fibroblasts, but not in the normal epithelia and tumor cells. (A)
Weak staining in distant normal mucosa. (B) Increased expression in
adjacent normal mucosa and even stronger staining in primary tumor. (C)
The strongest expression in lymph node metastasis.
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Western Blot Analysis
Lysates from seven fresh frozen colon cancer tissues
contained differing amounts of PINCH protein (Figure 5,
lanes 4–10), consistent with the variability in PINCH protein
expression found by immunohistochemistry on the tissue
sections. As previously described, the antibody was raised to
a full-length recombinant human PINCH six-histidine fusion
protein (rPINCH) [5,6]. As show in lanes 1 to 3, the reaction
of PINCH antibody with the rPINCH fusion protein used as
the immunogen results in the detection of multiple bands.
PINCH protein migrates in polyacrylamide gel as a 37-kDa
monomer (lane 1), a 75-kDa apparent dimer (lanes 1 and 2),
and an anomalous migration band at about 50 kDa (lane 3),
even with adequate reduction of the sample using 2-mer-
captoethanol and dithiothreitol. The same multiple bands are
seen when immunoblots of rPINCH are stained with anti-HIS
to detect histidine residues, verifying that all the bands
correspond to the recombinant protein and not to cross-
reacting protein. Even other PINCH antibodies produced
using other recombinant PINCH immunogens show the
same pattern of multiple bands [3], indicating that authentic
PINCH migrates in SDS gels at several molecular weights.
These results are not likely to be caused by degradation as
they are found in freshly isolated cell lysates prepared with
protease inhibitors. Because the bands seen on our Western
blots of human colon tissues (lanes 4–10) are the same as
those found with rPINCH (lanes 1–3), it is our conclusion
that these bands represent authentic PINCH and not cross-
reacting protein. The antibody gives exceptionally clean
staining showing no reaction in the absence of PINCH
(e.g., there is no immunostaining of collagen in tissue
sections).
Immunofluorescence
Immunofluorescence of colon cancer frozen sections
showed PINCH immunostaining of the tumor-associated
stroma (Figure 6), confirming the results found by immuno-
histochemistry of formalin-fixed, paraffin-embedded colo-
rectal cancer tissue sections. Immunofluorescence also
revealed the presence of endothelial cells in the tumor-
associated stroma (staining for CD31; Figure 6A) and of
myofibroblasts (staining for SMA; Figure 6B). Some, but
not all, endothelial cells that stained for CD31 costained for
PINCH (Figure 6A), indicating that a proportion of endothe-
lial cells in the tumor vasculature expresses PINCH
protein. Dual immunofluorescence showed colocalization of
PINCH and SMA staining (Figure 6B), indicating that tumor-
associated myofibroblasts express PINCH protein.
Discussion
Immunostaining for PINCH in cancers was investigated only
by one study carried out on various common cancers, in
which staining intensity was increased in tumor-associated
stromal cells noted at the invasive margin [5], which led us to
hypothesize the linkage of PINCH expression with tumor
Table 1. PINCH Staining Intensity in the Distant Normal Mucosa, Adjacent Normal Mucosa, Primary Tumor, and Metastasis.
Location Number Negative Staining (%) Weak Staining (%) Moderate Staining (%) Strong Staining (%)
Distant normal mucosa 39 1 (2.6) 13 (33.3) 18 (46.1) 7 (18)
Adjacent normal mucosa 96 3 (3.1) 37 (38.6) 43 (44.8) 13 (13.5)
Primary tumor
Entire tumor 174 1 (0.6) 26 (15) 60 (34.4) 87 (50)
Invasive margin 165 1 (0.6) 28 (17) 43 (26) 93 (56.4)
Metastasis 26 0 2 (8) 1 (4) 23 (88)
Figure 2. The seven groups of PINCH expression patterns in 14 cases that
had a complete data set including the distant normal mucosa, adjacent
normal mucosa, primary tumor, and metastasis.
Figure 3. Expression of PINCH protein at the invasive margin (arrow) was
much stronger than in the inner tumor area.
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invasiveness. In this study, stromal staining for PINCH was
shown, in general, to be minimal in stromal cells adjacent to
areas of normal colonic epithelium and to be modestly to
strongly positive in stromal cells adjacent to colon cancer
cells. Stromal cells at the invasive edge typically had more
intense staining for PINCH than those within the tumor,
whereas intense stromal staining for PINCH was also noted
in lymph node metastases. The pattern of stromal staining
for PINCH in colorectal cancer confirms the pattern found in
the prior study [5] in a much larger series of patients.
This study shows for the first time that stromal staining for
PINCH is an independent prognostic indicator in colorectal
cancer. Multivariate analysis showed that PINCH immuno-
staining predicted outcome independent of sex, age, tumor
location, Dukes stage, growth pattern, differentiation, and
inflammatory infiltration. It is particularly notable that strong
stromal immunostaining for PINCH at the invasive margin
was associated both with better differentiation and worse
survival. Although better differentiation is usually considered
as a sign of favorable prognosis, the prognostic value of
histologic grade is still controversial. The finding raises the
possibility that it may identify a subset of patients with
colorectal cancer who have aggressive disease in spite of
favorable morphology.
Inflammatory infiltration is known to be a reflector of
tumor-associated immune response and is generally con-
sidered as cytotoxic for the tumor cells. The prognosis
advantage of strong inflammatory infiltration in colorectal
tumors has been demonstrated [7,8]. Myofibroblasts have
been considered to be associated with desmoplastic stro-
mal responses to tumor. Myofibroblasts are proposed to
Table 2. The Relationship of PINCH Expression at the Invasive Margin of
Primary Tumors with Clinicopathologic Variables.
Variable PINCH Expression at Tumor Invasive Margin
Weak (%) Strong (%) P
Sex
Male 38 (53) 53 (57) .59
Female 34 (47) 40 (43)
Age (year)
V 70 31 (43) 40 (43) 1.00
> 70 41 (57) 53 (57)
Tumor location
Right colon 27 (38) 34 (37) .91
Left colon 13 (18) 15 (16)
Rectum 31 (43) 43 (47)
Dukes stage
A 10 (14) 8 (9) .66
B 24 (33) 27 (30)
C 25 (35) 33 (37)
D 13 (18) 21 (24)
Growth pattern
Expansive 38 (54) 41 (46) .30
Infiltration 32 (46) 48 (54)
Differentiation
Better 42 (58) 70 (76) .02
Worse 30 (42) 21 (24)
Inflammatory infiltration
Weak 48 (80) 77 (92) .04
High 12 (20) 7 (8)
Figure 4. PINCH protein expression at the invasive margins in relation to
survival in patients with colorectal cancer.
Table 3. Multivariate Analysis of PINCH Expression, Sex, Age, Site, Dukes
Stage, Growth Pattern, Grade of Differentiation, and Inflammatory Infiltration
in Relation to Survival in Colorectal Cancer.




Weak 57 1.0 – .01
Strong 79 2.1 1.16–3.37
Sex
Male 82 1.0 – .67
Female 54 0.8 0.53–1.48
Age (year)
V 70 63 1.0 – .85
> 70 73 0.9 0.57–1.58
Tumor location
Proximal 54 1.0 – .18
Distal 82 0.7 0.41–1.18
Dukes stage
A + B 58 1.0 – < .0001
C + D 78 4.0 2.19–7.37
Growth pattern
Expansive 61 1.0 – .01
Infiltration 75 2.0 1.13–3.38
Differentiation
Better 98 1.0 – .0003
Worse 38 2.8 1.62–4.85
Inflammatory infiltration
Weak 119 1.0 – .89
Strong 17 1.1 0.40–2.86
Figure 5. Western blotting. Lanes 1 to 3: Recombinant full-length six-
histidine–PINCH fusion protein (rPINCH) as a monomer at about 37 kDa,
apparent dimer at about 75 kDa, and anomalous migration band at about 50
kDa. Lanes 4 to 10: The lysates contained variable amounts of PINCH protein
that migrated primarily as an apparent dimer.
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form a barrier to the migration of immunocompetent cells
toward the tumor, and hence to reduce immune surveil-
lance. In colon cancer stroma, there is a negative corre-
lation between inflammatory infiltration and the presence
of myofibroblasts [9]. In this study, strong stromal immu-
nostaining for PINCH was also associated with lack of
inflammatory infiltration, and PINCH was shown by immu-
nofluorescence to be present in stromal myofibroblasts,
suggesting that the upregulation of PINCH in myofibroblasts
may be the tumor-activated reaction against inflamma-
tory cell infiltration, leading to tumor progression. PINCH
was also shown to be present in a proportion of endothelial
cells of the tumor vasculature, suggesting that PINCH
protein is upregulated in tumor angiogenesis, which is
particularly important and indispensable for tumor growth
and metastasis.
Taken together, the finding reported here, that PINCH is
upregulated in specific cells of the tumor-associated stroma,
including fibroblasts, myofibroblasts, and endothelial cells,
supports the hypothesis that PINCH is involved in promoting
tumor–stromal interactions that support tumor progression.
Interestingly, strong immunostaining stroma for PINCH at
the invasive margin is an independent prognostic indicator
in colorectal cancer.
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